1. Cell Biology
  2. Developmental Biology

BICC1 interacts with PKD1 and PKD2 to drive cystogenesis in ADPKD

  1. Uyen Tran
  2. Andrew J Streets
  3. Devon Smith
  4. Eva Decker
  5. Annemarie Kirschfink
  6. Lahoucine Izem
  7. Jessie M Hassey
  8. Briana Rutland
  9. Manoj K Valluru
  10. Jan Hinrich Bräsen
  11. Elisabeth Ott
  12. Daniel Epting
  13. Tobias Eisenberger
  14. Albert CM Ong  Is a corresponding author
  15. Carsten Bergmann  Is a corresponding author
  16. Oliver Wessely  Is a corresponding author
  1. Department of Heart, Blood & Kidney Research, Cleveland Clinic Research, Cleveland Clinic, United States
  2. Kidney Genetics Group, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, United Kingdom
  3. Medizinische Genetik Mainz, Limbach Genetics, Germany
  4. Department of Human Genetics, RWTH University, Germany
  5. Institute of Pathology, Medizinische Hochschule Hannover, Germany
  6. Department of Medicine IV, Faculty of Medicine, Medical Center-University of Freiburg, Germany
https://doi.org/10.7554/eLife.106342.3
Share this article
Cite this article
  1. Uyen Tran
  2. Andrew J Streets
  3. Devon Smith
  4. Eva Decker
  5. Annemarie Kirschfink
  6. Lahoucine Izem
  7. Jessie M Hassey
  8. Briana Rutland
  9. Manoj K Valluru
  10. Jan Hinrich Bräsen
  11. Elisabeth Ott
  12. Daniel Epting
  13. Tobias Eisenberger
  14. Albert CM Ong
  15. Carsten Bergmann
  16. Oliver Wessely
(2026)
BICC1 interacts with PKD1 and PKD2 to drive cystogenesis in ADPKD
eLife 14:RP106342.
https://doi.org/10.7554/eLife.106342.3
  2. Download BibTeX
  3. Download .RIS
7 figures, 1 table and 2 additional files

Figures

Figure 1 with 1 supplement
Download asset Open asset
mBicc1 forms a complex with Polycystin-1 and Polycystin-2.

Full-length and deletion myc-tagged constructs of mBicc1 were co-expressed with either full-length HA-tagged PC1 or PC2 in HEK-293 cells and tested for their ability to interact by co-IP. (a) Schematic diagram of the constructs used in this experiment. (b) Western blot analysis following co-IP experiments, using GST tagged constructs as bait, identified protein interactions between PC1 or PC2 domains and mBicc1. pcDNA3 was included as a negative control. CT = C-terminus, NT = N-terminus, GST = glutathione S-Transferase. Co-IP experiments (n=3) were quantified in (e). (c) Western blot showing expression of recombinant myc-tagged mBicc1 generated by in vitro translation or myc-tagged mBicc1 transfected in HEK-293 cells. (d) Western blot analysis following in vitro pulldown experiments, using purified GST tagged constructs as bait, identified direct protein interactions between PC1 or PC2 domains and in vitro translated myc-Bicc1. In vitro binding experiments (n=3) were quantified in (f). (g) Western blot analysis following co-IP experiments, using a rabbit PC1 antibody (2b7) as bait, identified protein interactions between endogenous PC1 and BICC1 in UCL93 cells. A non-immune rabbit IgG antibody or no antibody was included as a negative control; * denotes a non-specific IgG band which is not present in the no antibody control lane. (h) Western blot analysis following co-IP experiments, using an anti-BICC1 or anti-PC2 antibody as bait, identified protein interactions between endogenous PC2 and BICC1 in UCL93 cells. Non-immune goat and mouse IgG was included as a negative control.

Figure 1—source data 1

Original western blots for Figure 1, indicating the relevant bands.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig1-data1-v1.zip
Figure 1—source data 2

Original files for western blot displayed in Figure 1.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig1-data2-v1.zip
Figure 1—figure supplement 1
Download asset Open asset
In vitro binding assays showing direct binding between Bicc1, PC1-PLAT, and PC1-CT1, but not PC2-CT2.

In vitro translated myc-mBicc1 was incubated with recombinant MBP, MBP-PLAT, and MBP-CT1 or GST, GST-CT2 and subjected to IP with an anti-c-myc antibody (a) or pull-down with GST beads (b). MBP or GST was used as a negative control in each respective assay. Arrows indicate the pull down of MBP-PLAT and MBP-CT1, respectively; asterisk indicates non-specific band (a). GST-CT2 did not bind to myc-mBicc1 directly in vitro (b). Quality of the different recombinant proteins used is shown by Coomassie staining (c). GST pull-down identified an interaction between co-expressed GST-CT1 and myc-mBicc1 but not with GST (d).

Figure 1—figure supplement 1—source data 1

Original western blots for Figure 1—figure supplement 1, indicating the relevant bands.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig1-figsupp1-data1-v1.zip
Figure 1—figure supplement 1—source data 2

Original files for western blot displayed in Figure 1—figure supplement 1.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig1-figsupp1-data2-v1.zip
Figure 2
Download asset Open asset
Interactions between mBicc1 and Polycystin1/2 require different binding motifs.

Full-length and deletion myc-tagged constructs of mBicc1 were co-expressed with either full-length HA-tagged PC1 or PC2 in HEK-293 cells and tested for their ability to interact by co-IP. (a) Schematic diagram of the constructs used in this set of experiments with the amino acid positions of full-length mBicc1 or the different deletions indicated. (b, c) Western blot analysis following co-IP experiments, using a PC1-HA-tagged construct as bait, identified protein interactions between PC1 and mBicc1 domains. pcDNA3 was included as a negative control (b). co-IP experiments (n=3) were quantified in (c). (d, e) Western blot analysis following co-IP experiments, using a PC2-HA tagged construct as bait, identified protein interactions between PC2 and mBicc1 domains (d). pcDNA3 was included as a negative control. Quantification of the co-IP experiments (n=3) is shown in (e). (f, g) Western blot analysis following co-IP experiments, using a PC1-HA-tagged construct as bait. The interaction between PC1 and PC2 was not altered in the presence of either full-length mBicc1 or its deletion domains. pcDNA3 was included as a negative control. Asterix represents non-specific interaction with mouse IgG. (f). co-IP experiments (n=3) were quantified in (g). One-way ANOVA comparisons were performed to assess significance, and p values are indicated. Error bars represent standard error of the mean.

Figure 2—source data 1

Original western blots for Figure 2, indicating the relevant bands.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig2-data1-v1.zip
Figure 2—source data 2

Original files for western blot displayed in Figure 2.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig2-data2-v1.zip
Figure 3 with 1 supplement
Download asset Open asset
Cooperativity of Bicc1 and PKD genes in Xenopus.

(a–d) mRNA expression of Pkd1, Pkhd1, Pkd2, and Bicc1 in the Xenopus pronephros at stage 39. (e–i”) Knockdown of Bicc1 (f–f”), Pkd1 (g–g”), Pkd2 (h–h”), and Pkhd1 (i–i”) by antisense morpholino oligomers (MOs) results in a PKD phenotype compared to uninjected control Xenopus embryos (e–e”). The phenotype is characterized by the formation of edema due to kidney dysfunction (e, f, g, h, i; stage 43), the development of dilated renal tubules (e’, f’, g’, h’, i’; stage 43), and the loss of Nbc1 in the late distal tubule by whole mount in situ hybridizations (arrowheads in e”, f”, g”, h”, i”; stage 39). (j, k) To examine cooperativity, Xenopus embryos were injected with suboptimal amounts of the MOs, either alone or in combination, and analyzed for edema formation at stage 43 (j) and the expression of Nbc1 at stage 39 (k) with gray bars showing reduced and black bars showing absent Nbc1 expression in the late distal tubule. Data are the accumulation of multiple independent fertilizations with the number of embryos analyzed indicated above each condition.

Figure 3—figure supplement 1
Download asset Open asset
Validation of Xenopus knockdowns and BICC1 knockout.

(a) qRT-PCR detecting the region targeted by the Pkhd1-sMO using a PrimeTime qPCR assay (IDT). Xenopus embryos were injected with the indicated amount of Pkhd1-sMO and harvested at stage 39 for mRNA extraction. Individual dots indicate pools of five embryos each utilizing three independent fertilizations. Data were analyzed by Mann–Whitney test with one asterisk indicating p≤0.05 and two asterisks indicating p≤0.01. (b) To examine cooperativity between Bicc1 and the PKD genes, each MO was titrated for efficacy alone or tested in combination. Embryos were analyzed for edema formation at stage 43. Data are the accumulation of multiple independent fertilizations with the number of embryos analyzed indicated above each condition. Part of the data is shown in Figure 3j. (c) qRT-PCR for BICC1 comparing wildtype cells to the two genetically engineered BICC1 knockout clones. (d) qRT-PCR for PLD2 shows that re-expression of mBicc1, but not the empty vector (pCS2), restored PKD2 mRNA expression in a HEK293T BICC1 KO clone. (e, f) qRT-PCR for NEFL and LAMB3, which are both downregulated in the HEK293T BICC1 KO clone and restored upon re-expression of mBicc1.

Figure 4 with 1 supplement
Download asset Open asset
Cooperativity of Bicc1 and Pkd1 and Pkd2 in mouse.

(a–c) Bicc1 and Pkd2 interact genetically. Offspring from Bicc1;Pkd2 compound mice at postnatal day P4 and P14 are compared by outside kidney morphology at postnatal day P14 (a, scale bar is 2 mm), and kidney to body weight ratio (KW/BW) at P14 (b) and P4 (c). (d–g) Bicc1 and Pkd1 interact genetically. Bicc1;Pkd1 compound mice are compared by outside kidney morphology at P14 showing a kidney from Bicc1Bpk/Bpk:Pkd1+/+ and a Bicc1Bpk/Bpk:Pkd1+/CD- littermate (d, scale bar is 2 mm, as no wildtype littermate was present in the litter, no wildtype kidney is shown), estimation plot of KW/BW ratio comparing littermates at P14 with a p-value=0.092 (e), and cystic index, that is, percent of proximal tubules (PT) and collecting ducts (CD) cysts in respect to the total kidney area at P7 (f) and P14 (g). Two-sided paired t-tests were performed to assess significance, and the p-values are indicated; error bars represent standard deviation. (h–k) qRT-PCR analysis for Bicc1, Pkd1, and Pkd2 expression (h–j) and quantification of the PC2 expression levels by western blot (k) in kidneys at P4 before the onset of a strong cystic kidney phenotype. Data were analyzed by t-test, and the p-values are indicated. Please note that the y-axes of the different panels are intentionally different to best visualize the changes between the groups analyzed.

Figure 4—figure supplement 1
Download asset Open asset
Kidney parameters of Bicc1:Pkd2 and Bicc1:Pkd1 compound mutants.

(a ,b) Comparison of blood urea nitrogen (BUN) levels of kidneys of the Bicc1:Pkd2 crosses at postnatal day P14 and P21. (c, d) Comparison of kidney weight/body weight ratios (KW/BW) levels of kidneys of Bicc1:Pkd1 crosses and their respective BUN levels at postnatal day P14. (e) Immunoprecipitation of PC2 from kidneys of Bicc1+/+ and Bicc1Bpk/Bpk mice at postnatal day P4. 200 µg total protein from each sample was used to immunoprecipitate PC2 with 5 µg Ycc2 antibody and agarose-bound protein A/G. PC2 was detected using another antibody against Pkd2 (Sc-28331).

Figure 4—figure supplement 1—source data 1

Original western blots for Figure 4—figure supplement 1, indicating the relevant bands.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig4-figsupp1-data1-v1.zip
Figure 4—figure supplement 1—source data 2

Original western blots for Figure 4—figure supplement 1, indicating the relevant bands.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig4-figsupp1-data2-v1.zip
Figure 5
Download asset Open asset
Identification of human BICC1 variants.

(a–c) BICC1 p.G821E/PKD2 p.C632R patient with pedigree and the electropherograms (a), the structural analysis of the PKD2 showing the local structure around the cysteine at position 632 (indicated in red) and its putative impact in the variant including the REVEL score (b) as well as its location within the global PC2 structure highlighting the potential of the variant impacting the PC2 ion channel function (c). (d, e) Western blot analysis for PC2 comparing wildtype HEK293T, HEK293T BICC1 p.Gly821Glu (BICC1-G821E), HEK293T BICC1 p.Ser240Pro (BICC1-S240P) and HEK293T BICC1 knockout (BICC1-KO) cells and quantification thereof. γ-Tubulin was used as loading control. (f–i) BICC1 c.1179+1G>T/PKD1 p.Ala3981Val patient with pedigree and the electropherograms (f), the ultrasound analysis of the left and right kidneys (g, h) and the structural analysis of the PC1 showing the local structure around the alanine at position 3981 (indicated in red) and its putative impact in the variant including the REVEL score (i).

Figure 5—source data 1

Original western blots for Figure 5, indicating the relevant bands.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig5-data1-v1.zip
Figure 5—source data 2

Original files for western blot displayed in Figure 5.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig5-data2-v1.zip
Figure 6 with 1 supplement
Download asset Open asset
The homozygous BICC1 p.Ser240Pro variant is a hypomorphic cystic disease-causing variant.

(a–e) Consanguineous multiplex pedigree with two siblings affected by VEO-ADPKD identified the homozygous BICC1 missense variant c.718T>C (BICC1 p.Ser240Pro) absent from gnomAD and other internal and public databases. Electropherogram is shown in (a). The affected girl presented at a few months of age with renal failure and enlarged polycystic kidneys that lacked corticomedullary differentiation (c). Histology after bilateral nephrectomy showed polycystic kidneys more suggestive of ADPKD than ARPKD without any dysplastic element. Her younger brother exhibited enlarged hyperechogenic polycystic kidneys prenatally by ultrasound (b). In addition, in his early infancy, arterial hypertension and a Dandy–Walker malformation with a low-pressure communicating hydrocephalus were noted (d, e). (f) Ribbon diagram and schematic diagram of BICC1 showing the KH, KHL, and SAM domains. The two BICC1 variants identified in this study, BICC1 p.Ser240Pro (S240P) and BICC1 p.Gly821Glu (G821E) are indicated in red. (g) Solid boxes correspond to local impacts of p.Ser240Pro (p.S240P) on BICC1 structure, interactions are labeled as dashed lines (pseudobonds). GXXG motifs colored in magenta, representative missense variant residues colored in red and residues adjacent to selected variant (<5 Å) colored in tan. (h) Rescue experiments of Xenopus embryos lacking BicC1 by co-injections with the wild type or mutant constructs. Embryos were scored for the re-expression of Nbc1 in the late distal tubule by whole mount in situ hybridizations. Quantification of at least 3 independent experiments is shown. (i, j) HEK293T cells were transfected with Flag-tagged constructs of wild type or mutant Bicc1 and the subcellular localization of Bicc1 was visualized (red). Nuclei were counterstained with DAPI (blue). (k) Protein stability analysis using tetracycline-inducible HEK293T cells comparing the expression levels of Bicc1 and Bicc1-S240P 24 hours after removal of tetracycline and addition of cycloheximide. γ-Tubulin was used as loading control. The percentage of protein destabilization because of protein synthesis inhibition by cycloheximide is indicated. (l) Western Blot analysis of wildtype HEK293T, cells lacking BICC1 (BICC1-KO) and isogenic cells with the BICC1 p.Ser240Pro (BICC1-S240P) variant for PC2 expression. GAPDH was used as loading control. (m, n) Bar graph of the mRNA-seq transcriptomic analysis comparing BICC1 wildtype, knockout, and S240P isogenic HEK293T cells showing the eight most significantly upregulated transcripts (based on their Padj levels) in the BICC1 KO cells (m). For each gene, the normalized expression levels from each of the 6 samples (2 wildtype, KO, and 240 P each) are shown. (n) GSEA plot showing the enrichment of the Hallmark Epithelial_Mesenchymal_Transition data set in the BICC1-KO cells vs. the BICC1-S240P cells.

Figure 6—source data 1

Original western blots for Figure 6, indicating the relevant bands.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig6-data1-v1.zip
Figure 6—source data 2

Original files for western blot displayed in Figure 6.

https://cdn.elifesciences.org/articles/106342/elife-106342-fig6-data2-v1.zip
Figure 6—figure supplement 1
Download asset Open asset
Transcriptomic analysis of BICC1 wildtype, BICC1KO, and BICC1-S240P HEK293T cells.

(a–g) mRNA-seq data were analyzed using DESeq2 differential expression analysis using two samples per genotype. Venn Diagrams were used to visualize the distribution of the up- or downregulated transcripts (a, e); for each intersection, the eight most significantly altered transcripts (based on their Padj levels) are visualized in a bar diagram showing the normalized expression levels for each sample (b–d, f, g).

Author response image 1
Download asset Open asset
Model of BICC1, PC1 and PC2 self-regulation.

In this model Bicc1 acts as a positive regulator of PKD gene expression. In the presence of ‘sufficient’ amounts of PC1/PC2 complex, it is tethered to the complex and remains biologically inactive (Fig. 1A). However, once the levels of the PC1/PC2 complex are reduced, Bicc1 is now present in the cytoplasm to promote expression of the PKD proteins, thereby raising their levels (Fig. 4B), which then in turn will ‘shutdown’ Bicc1 activity by again tethering it to the plasma membrane.

Tables

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Cell line
(Homo sapiens)		HEK-293ETCC and ATTC
Cell line
(H. sapiens)		UCL-93Streets et al., 2003
Parker et al., 2007		PMID:12819240

PMID:17396115
AntibodyAnti-Polycystin-1 (7e12, mouse monoclonal)Santa Cruz Biotechnologies
Ong et al., 1999		sc-130554, RRID:AB_2163355
PMID:10504485
Used @ 1:5000
AntibodyAnti-Polycystin-1 (2b7, rabbit polyclonal)Newby et al., 2002PMID:119011445 μg used for IP
AntibodyAnti-Polycystin-2 (YCC2, rabbit polyclonal)Kind gift from Dr. S. SomloPMID:9568711Used @ 1:1000
AntibodyAnti-Polycystin-2 (D-3, mouse monoclonal)Santa Cruz Biotechnologiessc-28331,
RRID:AB_672377		Used @ 1:1000
AntibodyAnti-Polycystin-2 (G20, goat polyclonal)Santa Cruz Biotechnologiessc-10376,
RRID:AB_654304		Used @ 1:1000
AntibodyAnti-myc (JAC6, rat monoclonal)Bio-RadMCA1929,
RRID:AB_322203		Used @ 1:2000
AntibodyAnti-GST (rabbit polyclonal)Santa Cruz Biotechnologiessc-459,
RRID:AB_631586		Used @ 1:5000
AntibodyAnti-BICC1 (A-12, mouse monoclonal)Santa Cruz Biotechnologiessc-514846,
RRID:AB_3717417		Used @ 1:2000
Antibodyanti-BICC1 (rabbit polyclonal)Sigma-AldrichHPA045212,
RRID:AB_10959667		Used @ 1:2000
AntibodyAnti-γ-Tubulin (mouse monoclonal)Sigma-AldrichT6557,
RRID:AB_477584		Used @ 1:1000
AntibodyAnti-HA (3F10, rat monoclonal)Roche11867423001,
RRID:AB_390918		Used @ 1:2000
AntibodyAnti-V5-Tag
(clone SV5-Pk1, mouse monoclonal)		Bio-RadMCA1360, RRID:AB_322378Used @ 1:5000
AntibodyAnti-MBP (rabbit polyclonal)NEBE8030S,
RRID:AB_1559728		Used @ 1:5000
AntibodyAnti-GST (mouse monoclonal)Santa Cruz Biotechnologiessc-138,
RRID:AB_627677		Used @ 1:5000
AntibodyAnti-GAPDH (rabbit monoclonal)Cell Signaling2118, RRID:AB_561053Used @ 1:1000
AntibodyGoat Anti-Rabbit IgG(H+L), Mouse/Human ads-HRPSouthern Biotech4050-05Used @ 1:20,000
AntibodyMouse IgG1-human ads HRPSouthern Biotech1070-05Used @ 1:20,000
AntibodyAnti-Rat IgG(H+L) Mouse adsSouthern Biotech3050-05Used @ 1:20,000
AntibodyAnti-Goat Ig HRPDakoP0449Used @ 1:20,000
Peptide, recombinant proteinanti-HA mouse conjugated magnetic beadsThermo Fisher Scientific88836
Peptide, recombinant proteinProtein G Magnetic BeadsThermo Fisher Scientific10003D
Recombinant DNA reagentmyc-mBICC1pcDNA3Wessely lab
PMID:20215348
Recombinant DNA reagentmyc-mBICC1-ΔKHpcDNA3Ong lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentmyc-mBICC1-ΔSAMpcDNA3Ong lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentGST-NT2-1-100pEBGOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentPC1-HApcDNA3Ong lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentHA-PC1-R4227XpcDNA3Ong lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentPC2-HApcDNA3Ong lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentGST-NT2 101-223pEBGOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentGST-CT1pEBGOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentGST-CT1-4227XpEBGOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentGST-NT2pEBGOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentGST-CT2pEBGOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentMBP-CT1pMAL-c2xOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentMBP-CT2pMAL-c2xOng lab
PMID:20168298
PMID:26311459
Recombinant DNA reagentMBP-PLATpMAL-c2xOng lab
PMID:20168298

PMID:26311459
Commercial assay or kitOmega E.Z.N.A. Plasmid DNA Mini KitOmega Bio-TekD6942-01

Additional files

Supplementary file 1

Supplementary tables.

(a) Table of the expected vs. observed frequencies in the Bicc1+/Bpk:Pkd2+/+ x Bicc1+/Bpk:Pkd2+/-crosses at P21. (b) Table of the expected vs. observed frequencies in the Bicc1+/Bpk:Pkd1+/+:Pkhd1-Cre+ x Bicc1+/Bpk:Pkd1+/fl crosses at P14. (c) Table of the in silico analysis of the PKD1 and PKD2 variants identified in VEO-ADPKD patients. (d) Table of the in silico analysis of the BICC1 p.Ser240Pro (S240P) variant. (e) Table of the gene sets enriched in BICC1-KO vs. BICC1-S240P HEK293T cells.

https://cdn.elifesciences.org/articles/106342/elife-106342-supp1-v1.docx
MDAR checklist
https://cdn.elifesciences.org/articles/106342/elife-106342-mdarchecklist1-v1.pdf

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Uyen Tran
  2. Andrew J Streets
  3. Devon Smith
  4. Eva Decker
  5. Annemarie Kirschfink
  6. Lahoucine Izem
  7. Jessie M Hassey
  8. Briana Rutland
  9. Manoj K Valluru
  10. Jan Hinrich Bräsen
  11. Elisabeth Ott
  12. Daniel Epting
  13. Tobias Eisenberger
  14. Albert CM Ong
  15. Carsten Bergmann
  16. Oliver Wessely
(2026)
BICC1 interacts with PKD1 and PKD2 to drive cystogenesis in ADPKD
eLife 14:RP106342.
https://doi.org/10.7554/eLife.106342.3